Vedolizumab for Chronic Pouchitis: Assessing How Effective and Safe it is

Trial Details

  • 200 patients will be taking part in this study
  • Condition: Ulcerative Colitis
  • Intervention: Vedolizumab + Ciprofloxacin or Vedolizumab + Placebo
  • Clinic: GI Research Institute Suite 770-1190 Hornby Street

Summary

The purpose of this study is to assess how effective and safe vedolizumab intraveneous (IV) is in people with ulcerative colitis who have had bowel surgery involving a proctocolectomy and ileal pouch anal anastomosis, and now have chronic or recurrent pouchitis, or require continuous antibiotic treatment.

Full Trial Details

Researchers

Dr. Brian Bressler

Gastroenterologist

Brian bressler headshot for dt trial listings